Allied Market Research
Loading...
0
Allied Market Research

Autologous Cell Therapy Market by Source (Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, and Chondrocytes), Application (Cancer, Neurodegenerative Diseases, Wound Healing, Orthopedic, Cardiovascular Diseases, and Autoimmune Diseases) and End User (Hospitals, Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2028

A11534
Pages: NA
Aug 2021 | 76 Views
   
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Autologous Cell Therapy Market

Request Now !

Autologous Cell Therapy Market Overview:

Autologous cell therapy is a therapeutic intervention with stem cells where the patient’s stem cells are cultured and then expanded outside the body. These cells are then reintroduced in the body of the same patient. This therapy has lesser risks, as there are lesser chances of rejection of the cells that are reintroduced as they come from the same person. Over the years, autologous cell therapy has been used in the treatment of many chronic illnesses such as various forms of cancer and even blood disorders like thalassemia.

Autologous-Cell-Therapy

Market Scope and Structure Analysis

Report Metric

Details

Market Size Available for Years

  2020–2028

  Base Year Considered

  2020

  Forecast Period

  2021–2028

  Forecast Unit

  Value (USD)

  Segments Covered

  Source, Application, End User, and Region

  Regions Covered

  North America, Europe, Asia-Pacific, and LAMEA

  Companies Covered

Bayer AG, Daiichi Sankyo Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Holostem Terapie Avanzate Srl, Vericel Corp., Osiris Therapeutics Inc., Brainstorm Cell Therapeutics Inc., Sumitomo Chemical Co. Ltd., and FUJIFILM Holdings Corp.

 

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industry industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the autologous cell therapy market.

Top Impacting Factors

An increase in the number of people undergoing severe conditions has generated a requirement for autologous cell therapy, which drives the growth of the global autologous cell therapy market. Autologous cell therapy has a moderate risk of complexities when compared to other treatments, which acts as a key growth driver of the autologous cell therapy market.

The major determinants attributing to the growth of this market are increase in cases of chronic diseases such as autoimmune diseases, blood disorders, and cancer. Furthermore, endowments and investments done to the research facilities by public and private sectors help the market grow.

Other factors that are expected to propel the market growth are enhanced survival rate of patients, high affordability, no obligation for identification of an HLA-matched donor, and no chances of graft versus host diseases.

However, the cost of processing the autologous cell therapy is high, which restrains the autologous cell therapy market growth. However, if there is government intervention[AT1] in reimbursements through medical insurances, this restraint could be possibly removed.

Key Market Trends

To gain a larger share in the global autologous cell therapy market, major players are focusing on strategies such as mergers & acquisitions, product innovations, joint ventures, partnerships, and collaborations.

In April 2019, Hitachi Chemical Co. Ltd. acquired apceth Biopharma GmbH to extend its footprint for gene and cell therapeutics production in the contract development and manufacturing organization (CDMO) market.

In August 2019, BlueRock Therapeutics was acquired by Bayer, Inc. to maintain its place in the cell therapy market. BlueRock Therapeutics is a U.S.-based corporation that relies on establishing successful pluripotent stem cell preparations that are used in cell therapy development.

In August 2017, the merger and acquisition deal between Calimmune, Inc. and CSL Behring took effect. With this, Calimmune, Inc. offers CSL Behring with CAL-H, clinical asset, and hematopoietic stem cell (HSL) gene therapy for thalassemia and sickle cell disease therapy. It complements CSL Behring's extensive expertise in hematology and the current product portfolio.

Key Segments Covered

Segment

Subsegment

  Source

  • Bone Marrow
  • Epidermis
  • Mesenchymal Stem Cells
  • Hematopoietic Stem Cells,
  • Chondrocytes

  Application

  • Cancer
  • Neurodegenerative Diseases
  • Wound Healing
  • Orthopedic
  • Cardiovascular Diseases
  • Autoimmune Diseases

  End User

  • Hospitals
  • Clinics
  • Others

  Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

Key Benefits of the Report

  • This study presents the analytical depiction of the autologous cell therapy industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the autologous cell therapy market share.
  • The current market is quantitatively analyzed from 2020 to 2028 to highlight the autologous cell therapy market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed autologous cell therapy market analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Global Autologous Cell Therapy Market Report

  • Which are the leading players active in the autologous cell therapy market?
  • How is each segment of the market expected to grow during 2021–2028?
  • What are the adoption trends for autologous cell therapy in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is autologous cell therapy?
  • What is autologous cell therapy market prediction in the future?
  • What are the current trends and predicted trends?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285,
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

RELATED TAGS

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Autologous Cell Therapy Market

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995  $8,996
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers